Q3 2017 Holdings
Filed 2017-11-14 | 159 holdings | $6.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biocryst Pharmaceuticals(BCRX) | COM | 09058V103 | $298.0K | 56,873 | 4.7% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $339.0K | 23,395 | 5.3% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $430.0K | 6,435 | 6.7% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $437.0K | 24,077 | 6.9% |
| Akebia Therapeutics Inc(AKBA) | COM | 00972D105 | $453.0K | 23,019 | 7.1% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $518.0K | 4,411 | 8.1% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $839.0K | 8,113 | 13.2% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $1.0M | 11,260 | 16.4% |
| Biogen Inc(BIIB) | COM | 09062X103 | $1.3M | 4,085 | 20.1% |